Literature DB >> 11120786

CDK4 expression and activity are required for cytokine responsiveness in T cells.

J F Modiano1, J Mayor, C Ball, M K Fuentes, D S Linthicum.   

Abstract

Stimulation of lymphocytes through the Ag receptor can lead to cytokine responsiveness or unresponsiveness. We examined the importance of cyclin-dependent kinase (CDK)4 to establish and maintain IL-2 responsiveness in human T cells. Our results show that a herbimycin A- and staurosporine-sensitive phase of CDK4 expression and activity preceded the acquisition of IL-2-responsiveness in mitogen-stimulated peripheral blood T cells. Intriguingly, CDK4 expression and activity were demonstrable in purified unstimulated peripheral blood T cells from approximately 30% (5/16) of healthy individuals examined for this study. These T cells proliferated in response to IL-2 without additional mitogens, and both the expression and activity of CDK4 and the ability to respond to cytokines were resistant to herbimycin A and staurosporine. The pattern of CDK4 expression and response to IL-2 in this subset of individuals resembled that seen in the human IL-2-dependent Kit-225 T cell line. However, in contrast to normal T cells, Kit-225 cells were rendered unresponsive to IL-2 by stimulation through the Ag receptor. In these cells, PHA, anti-CD3, or PMA induced marked reductions of CDK4 expression and activity that paralleled IL-2 unresponsiveness, and these effects were not reversible by IL-2. Furthermore, IL-2-dependent proliferation could be similarly inhibited in Kit-225 cells by overexpression of the CDK inhibitors p16/Ink4-a or p21/Waf-1a or by overexpression of a kinase-inactive CDK4 mutant. The data indicate that CDK4 expression and activity are necessary to induce and maintain cytokine responsiveness in T cells, suggesting that CDK4 is important to link T cell signaling pathways to the machinery that controls cell cycle progression.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11120786     DOI: 10.4049/jimmunol.165.12.6693

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  10 in total

Review 1.  Negative regulators in homeostasis of naïve peripheral T cells.

Authors:  Jaime F Modiano; Lisa D S Johnson; Donald Bellgrau
Journal:  Immunol Res       Date:  2008       Impact factor: 2.829

2.  Dynamic edge-based biomarker non-invasively predicts hepatocellular carcinoma with hepatitis B virus infection for individual patients based on blood testing.

Authors:  Yiyu Lu; Zhaoyuan Fang; Meiyi Li; Qian Chen; Tao Zeng; Lina Lu; Qilong Chen; Hui Zhang; Qianmei Zhou; Yan Sun; Xuefeng Xue; Yiyang Hu; Luonan Chen; Shibing Su
Journal:  J Mol Cell Biol       Date:  2019-08-19       Impact factor: 6.216

3.  Aberrant Retinoblastoma (RB)-E2F Transcriptional Regulation Defines Molecular Phenotypes of Osteosarcoma.

Authors:  Milcah C Scott; Aaron L Sarver; Hirotaka Tomiyasu; Ingrid Cornax; Jamie Van Etten; Jyotika Varshney; M Gerard O'Sullivan; Subbaya Subramanian; Jaime F Modiano
Journal:  J Biol Chem       Date:  2015-09-16       Impact factor: 5.157

4.  Physical interaction of human T-cell leukemia virus type 1 Tax with cyclin-dependent kinase 4 stimulates the phosphorylation of retinoblastoma protein.

Authors:  Kerstin Haller; Yalin Wu; Elisabeth Derow; Iris Schmitt; Kuan-Teh Jeang; Ralph Grassmann
Journal:  Mol Cell Biol       Date:  2002-05       Impact factor: 4.272

5.  Development of an exosomal gene signature to detect residual disease in dogs with osteosarcoma using a novel xenograft platform and machine learning.

Authors:  Kelly M Makielski; Alicia J Donnelly; Ali Khammanivong; Milcah C Scott; Andrea R Ortiz; Dana C Galvan; Hirotaka Tomiyasu; Clarissa Amaya; Kristin A Ward; Alexa Montoya; John R Garbe; Lauren J Mills; Gary R Cutter; Joelle M Fenger; William C Kisseberth; Timothy D O'Brien; Brenda J Weigel; Logan G Spector; Brad A Bryan; Subbaya Subramanian; Jaime F Modiano
Journal:  Lab Invest       Date:  2021-09-06       Impact factor: 5.662

Review 6.  Therapeutic potential of CDK4/6 inhibitors in renal cell carcinoma.

Authors:  Rebecca A Sager; Sarah J Backe; Elham Ahanin; Garrett Smith; Imad Nsouli; Mark R Woodford; Gennady Bratslavsky; Dimitra Bourboulia; Mehdi Mollapour
Journal:  Nat Rev Urol       Date:  2022-03-09       Impact factor: 16.430

7.  Regulation of alloimmune Th1 responses by the cyclin-dependent kinase inhibitor p21 following transplantation.

Authors:  Theodore H Welling; Guanyi Lu; Keri Csencsits; Sherri C Wood; Lamis Jarvinen; D Keith Bishop
Journal:  Surgery       Date:  2007-12-21       Impact factor: 3.982

8.  MHC-dependent desensitization of intrinsic anti-self reactivity.

Authors:  Cristan M Jubala; Angela R Lamerato-Kozicki; Michelle Borakove; Julie Lang; Lori A Gardner; David Coffey; Karen M Helm; Jerome Schaack; Monika Baier; Gary R Cutter; Donald Bellgrau; Jaime F Modiano
Journal:  Cancer Immunol Immunother       Date:  2008-06-04       Impact factor: 6.968

9.  Genetic disruption of p38alpha Tyr323 phosphorylation prevents T-cell receptor-mediated p38alpha activation and impairs interferon-gamma production.

Authors:  Ludmila Jirmanova; Dandapantula N Sarma; Dragana Jankovic; Paul R Mittelstadt; Jonathan D Ashwell
Journal:  Blood       Date:  2008-11-14       Impact factor: 22.113

Review 10.  Targeting CDK4 and CDK6: From Discovery to Therapy.

Authors:  Charles J Sherr; David Beach; Geoffrey I Shapiro
Journal:  Cancer Discov       Date:  2015-12-11       Impact factor: 39.397

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.